FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure RFK Jr. & claimed regenerative peptides like BPC 157 The Niche Mark your calendar. July 23 24. FDA advisory committee reviewing BPC 157, TB 500, MOTS C, semax, epitalon, KPV, and DSIP for the 503A compounding list. The peptide landscape could shift significantly. Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP 1 compounding while @martymakary is photographed holding bootleg # Peptides in 2026, What the FDA Review Means Olympia Pharmaceuticals